Skip to main content
NIH funding notice RFA-CA-22-055

Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)

Closed on November 21, 2022.

Posted
September 13, 2022
Close date
November 21, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$1,166,056
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 SRB-K (M3))1
1 award under RFA-CA-22-055 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Cancer Prevention-Interception Against MGUS Progression1U54CA272691-01A1Li, YongBAYLOR COLLEGE OF MEDICINE, TXFirst-year cost $1,166,056Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.